This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

12 Jul 2011

Isogenica Opens New Discovery Facility

Isogenica announced the opening of a new automation facility for the discovery of biological therapeutics, diagnostics and reagents.

Isogenica Ltd. has opened a new automation facility at its current location, Chesterford Research Park in Cambridge.


The new facility will house the high throughput CIS display platform for the discovery of biological therapeutics, diagnostics and reagents using Tecan liquid handling robots and screening equipment, adding capacity for the selection of next generation molecules for biopharmaceutical projects with as many as two hundred selections per week.


In March Isogenica entered a service agreement with Johnson & Johnson Pharmaceutical R&D for discovery work with the Centyrin scaffold. Also, in June the company partnered with Biolauncher and Cresset Biomolecular Discovery to develop an end-to-end small molecule discovery platform by integrating their e

Related News